Skip to main content

Table 2 Drug and alcohol use and treatment among patients with HIV infection whose medical records were reviewed, northeast Massachusetts, 2018 (N = 88)

From: An outbreak of HIV infection among people who inject drugs in northeastern Massachusetts: findings and lessons learned from a medical record review

  na %
Drug alcohol and drug use during the review period
 Active use in review period 63 72
 History of use/inactive in review period 8 9
 History of use/inactive in review period, on suboxone 11 13
 No history 5 6
 Missing 1 1
Among those with documented active drug or alcohol use (n = 63), substances used (categories not mutually exclusive)
 Alcohol 10 16
 Cocaine 34 54
 Heroin 50 79
 Other opiates 23 37
 Methamphetamine 1 2
 Recreational use of prescription drugs 1 2
 Not documented 3 5
 Otherb 8 13
Route of drug use (n = 63) (categories not mutually exclusive)
 Injection 59 94
 Intranasal 9 14
 Smoking 7 11
 Oral 9 14
 Not Documented 3 5
Treatment for drug/alcohol use for active substance users (n = 63), modality (categories not mutually exclusive)
 Medication assisted treatment 39 62
 In treatment, another modalityc 23 37
 Counseled by provider 15 24
 No action indicated 4 6
Among those reporting another modality of treatment (n = 23), modality (categories not mutually exclusive)
 Counseling 9 39
 Twelve-step program 3 13
 Halfway/sober house 9 39
 Other 10 43
  1. aMedical record review period was May 1, 2016 through date of data abstraction (abstraction done May 17 to June 6, 2018), and all characteristics were assessed during the review period
  2. bOther active substances include suboxone/fentanyl (n = 1), methadone/fentanyl (n = 1), bath salts (n = 1), benzodiazepine (n = 2), marijuana (n = 3)
  3. cIncludes dedicated drug or alcohol counseling program, 12-step program, halfway/sober house, and other [detox program (n = 6), referral made (n = 3), and residential program (n = 1)]